Sterile Water For Injection

A lab tech picks up a vial labeled "Sterile Water for Injection (SWFI)" and a colleague asks: Is this the same as bacteriostatic water? The answer matters. One supports short-term single-dose use; the other extends shelf life in multi-dose vials. Yet the two are often confused in procurement, leading to wrong product orders, wasted inventory, and unnecessary cost.

This article cuts through that confusion with the technical facts you need to specify SWFI in your own lab—and to understand when you should reach for bacteriostatic water instead.

What SWFI Actually Is

Sterile Water for Injection is defined in USP <71> (Sterility Tests) and further specified in USP <621> (Water for Pharmaceutical Purposes). The key distinction: SWFI contains no antimicrobial preservative. It is pyrogen-free water that has been sterilized and packaged to remain sterile until opened.

The practical implication is stark. Once you open a vial of SWFI, you have a narrow window—typically 24 hours at room temperature or up to 14 days under refrigeration at 2–8 °C—before microbial contamination becomes likely (USP <71> guidance on post-opening stability). A reconstituted compound left on the bench for 48 hours becomes risky.

Bacteriostatic water includes 0.9% benzyl alcohol as a preservative, which inhibits bacterial and fungal growth (USP <51>, Antimicrobial Effectiveness). This allows multi-dose vials to remain usable for weeks, provided aseptic technique is maintained throughout.

The Manufacturing and Testing Difference

Both products begin as deionized, purified water. Sterilization diverges next.

SWFI is sterilized by 0.22 μm membrane filtration or autoclaving at 121 °C for 15–30 minutes (USP <621>). Filtration removes particles >0.22 μm; autoclaving denatures pyrogenic contaminants through heat. Either method yields a pyrogen count of <0.175 USP endotoxin units per mL (USP <621>, Table 1: Water for Pharmaceutical Purposes, Endotoxin Limits).

Testing requirements are rigorous. Every lot of SWFI must pass:

• Sterility test (USP <71>): 14-day incubation in thioglycollate and soybean casein digest media
• Bacterial endotoxin test (USP <85>, LAL method): ≤0.25 USP Endotoxin Units per mL
• Particulate matter: ≤12 particles per mL ≥10 μm (USP <788>)

A single positive sterility result means batch rejection. No exceptions.

Bacteriostatic water undergoes identical testing plus verification that 0.9% benzyl alcohol concentration falls within 0.8–1.1% w/v (USP <51>). This narrow range matters: below 0.8%, preservative efficacy drops sharply; above 1.1%, benzyl alcohol toxicity emerges in vulnerable populations.

Real-World Specifications: What the CoA Tells You

Consider a concrete example. Hospira SWFI comes in 10 mL, 30 mL, and 500 mL vials. A typical Certificate of Analysis for 2025 includes:

| Parameter | Specification | Result | |-----------|---------------|--------| | Appearance | Clear, colorless | Pass | | Bacterial endotoxin | ≤0.25 USP EU/mL | 0.08 USP EU/mL | | Sterility | Negative (14-day) | Negative | | Particulate matter (≥10 μm) | ≤12 particles/mL | 2 particles/mL | | pH | 5.0–7.0 | 6.2 |

This confirms the batch meets USP <621> limits. The endotoxin result (0.08 EU/mL) sits well below the 0.25 EU/mL threshold—important if your compound will be administered parenterally.

BAC Water Depot, MedExSupply, and Mountainside Medical publish similar per-lot CoAs in downloadable documentation. Before accepting delivery, cross-check the batch number format and test dates against your supplier's certificate. (We've seen labs accept vials without CoA verification, only to discover batch failures during compounding—a costly mistake.) If a vendor cannot produce a CoA within 48 hours of your request, escalate the concern.

When to Use SWFI vs. Bacteriostatic Water

The decision is straightforward: SWFI for single-dose use or immediate consumption; bacteriostatic water for multi-dose vials.

SWFI is the right choice if:

• You are reconstituting a compound for immediate injection or use within hours
• You operate in a sterile environment with reliable aseptic technique and immediate administration
• Your compound is sensitive to benzyl alcohol—some peptides, certain monoclonal antibodies, and compounds validated in alcohol-free vehicles show degradation or aggregation when exposed to benzyl alcohol
• You are performing USP <797>-compliant pharmacy compounding and your SOP mandates preservative-free water for certain preparations

Bacteriostatic water is the right choice if:

• You are preparing multi-dose vials that will be stored and drawn from over days or weeks
• Your lab has validated aseptic technique with documented sampling plans (USP <1207>, Sterile Product Preparation)
• Cost per reconstitution matters; bacteriostatic water (typically $0.15–$0.25 per mL in bulk) costs less per mL than SWFI because one vial serves multiple uses
• You are handling peptides or research compounds that tolerate benzyl alcohol without loss of potency

Vendor Comparison: Cost and Logistics

BAC Water Depot stocks both products in 10 mL, 30 mL, and 500 mL sizes. Their SWFI ships non-hazardous (no surcharge), whereas bacteriostatic water requires hazardous-material designation in some states—adding 10–15% to freight cost.

Hospira SWFI enjoys wide distribution through pharmaceutical wholesalers with 24–48 hour availability. Batch consistency is high; backorders are uncommon.

MedExSupply emphasizes small-unit sales (boxes of 25 × 10 mL vials), while Mountainside Medical targets institutional buyers with larger pallet quantities. Both carry SWFI.

| Vendor | SWFI 30 mL (per vial) | Lead time | CoA availability | |--------|----------------------|-----------|------------------| | BAC Water Depot | $2.10–$2.40 | 1–2 days | Downloadable, per lot | | Hospira | $1.85–$2.20 | 1–2 days | On request (24–48 hours) | | MedExSupply | $2.30–$2.60 | 2–3 days | Downloadable, per lot | | Mountainside Medical | $1.95–$2.35 | 1–3 days | Downloadable, per lot |

Use these as ballpark figures for planning. Prices fluctuate month to month.

Storage and Shelf Life After Opening

SWFI degrades once exposed to air. The clock starts when you breach the vial seal. At room temperature (20–25 °C), the 24-hour window reflects airborne spore settlement risk. Under refrigeration (2–8 °C), extend that to 14 days—but only if you:

• Re-cap the vial immediately after each draw
• Use aseptic technique (70% isopropyl alcohol swab on the septum, sterile needle/syringe)
• Store in the dark; light promotes bacterial growth
• Prevent freezing

When SWFI reconstitutes a lyophilized powder, the resulting solution's stability depends on both the water and the drug substance. Always consult the drug's stability data. Some compounds remain stable for six months in SWFI under proper storage; others degrade within 48 hours.

Practical Recommendations

For procurement: Define your use case before ordering. Contract research labs (CROs) handling multiple peptide projects monthly find bacteriostatic water financially and operationally efficient. Clinical compounding pharmacies reconstituting single-dose preparations for same-day administration need SWFI as their baseline.

For validation: Scaling from bench to GLP-regulated work? Request a stability study comparing your compound in SWFI versus bacteriostatic water. Some compounds are indifferent; others show significant interaction with benzyl alcohol. Capture this data early.

For sourcing: Don't assume all SWFI is identical. Request CoAs before purchase. Check endotoxin values if the final product will be administered parenterally. Some suppliers consistently achieve 0.08–0.10 EU/mL, while others test at the upper limit (0.25 EU/mL). Small in absolute terms, yet the gap signals manufacturing discipline.

For storage: Keep SWFI in a climate-controlled cabinet (20–25 °C). Avoid direct sunlight. Treat opened vials as 24-hour resources; discard any remainder if you question technique or elapsed time.

---

Related reading: Bacteriostatic Water vs. Sterile Water—When to Use Which, Bacteriostatic Water Quality Checklist Before You Buy, Aseptic Technique for Multi-Dose Vial Draws

R. Calloway, Editor